A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma
Clinical trial NCT05055063 · RECRUITING
Trial details
- NCT number
- NCT05055063
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2027-02-02
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.